Medtronic Receives U.S. FDA Approval for Pipeline™ Flex Embolization Device with Shield Technology™
- Wednesday, April 21, 2021, 7:04
- Finance
- Add a comment
First Patient Receives New Shield Surface Modification, An Advance in Flow Diversion Therapy, at NYU Langone Health DUBLIN, April 21, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States…
About the Author
adminasapcorp has written 41884 stories on this site.